Rubella in Jerusalem. 1. Seroepidemiologic findings in children born after the 1972 rubella epidemic

Israel Journal of Medical Sciences
|September 1, 1978
PubMed

Insights

A severe rubella epidemic led to a study of 969 babies. Over 21% showed antibodies, indicating a significant risk of congenital rubella infection, highlighting the need for vaccination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • A significant rubella epidemic occurred prior to vaccine availability in Israel.
  • Congenital rubella syndrome (CRS) poses severe risks to newborns.
  • Understanding the seroprevalence of rubella antibodies in infants post-epidemic is crucial.

Purpose of the Study:

  • To determine the serologic evidence of congenital rubella infection in infants born after a major rubella epidemic.
  • To estimate the incidence of congenital rubella infection in the affected birth cohort.
  • To inform public health strategies regarding rubella prevention and control.

Main Methods:

  • Serologic testing of 969 infants at eight months of age using hemagglutination inhibition (HAI) antibody titers.
  • Clinical diagnosis of congenital rubella cases at birth and up to eight months.
  • Correlation of maternal rubella history with infant seropositivity.

Main Results:

  • 21.9% of infants (208/969) were seropositive for rubella antibodies (titer ≥ 1:16).
  • Congenital rubella was diagnosed in 7 infants at birth and 14 by eight months.
  • Late-onset signs of rubella developed in two infants considered normal at eight months.
  • Maternal rubella during pregnancy was clinically recognized in less than 3% of seropositive infants' mothers.
  • Estimated serologic evidence of congenital rubella infection ranged from 8.1% to 21.9%.

Conclusions:

  • The study indicates a substantial burden of congenital rubella infection following the epidemic, with significant serologic evidence in infants.
  • The findings underscore the importance of rubella vaccination programs, especially for women of childbearing age.
  • Continued surveillance and immunization efforts are essential to prevent future congenital rubella cases.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...